Version 1
: Received: 29 March 2022 / Approved: 31 March 2022 / Online: 31 March 2022 (10:01:28 CEST)
Version 2
: Received: 30 October 2022 / Approved: 31 October 2022 / Online: 31 October 2022 (09:27:48 CET)
How to cite:
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v1
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints 2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v1
Esquirol Caussa, J.; Herrero Vila, E.; Sánchez Aldeguer, J. Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints2022, 2022030404. https://doi.org/10.20944/preprints202203.0404.v1
APA Style
Esquirol Caussa, J., Herrero Vila, E., & Sánchez Aldeguer, J. (2022). Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines. Preprints. https://doi.org/10.20944/preprints202203.0404.v1
Chicago/Turabian Style
Esquirol Caussa, J., Elisabeth Herrero Vila and Josep Sánchez Aldeguer. 2022 "Use of a Polypill to Reduce Cardiovascular Risk Factors in Primary and Secondary Prevention: Review and Use Guidelines" Preprints. https://doi.org/10.20944/preprints202203.0404.v1
Abstract
INTRODUCTION: Primary and secondary cardiovascular prevention programs present less efficacy than desired due to the professionals’ lack of adherence when prescribing different drugs to the same patient, and due to patients’ lack of adherence in the medium and long term to medications prescribed. Polypills are considered as a possible solution to these problems. An evidence-based review about a cardiovascular prevention polypill efficacy and a guide for its use is presented.METHODS: Comprehensive bibliographical review of the evidence published on the polypill as a mechanism for facilitating medication adherence in primary and secondary cardiovascular prevention.RESULTS: A total of 31 published articles were included, showing the options of the polypill as a method of primary and secondary cardiovascular prevention. Polypill can increase the therapeutic adherence of patients in the medium and long term, also increasing therapeutic results compared to the administration of the same different drugs separately. Based on the evidence, a flow chart for the prescription of a polypill has been developed.DISCUSSION AND CONCLUSIONS: The use of a polypill increases the effectiveness and adherence of patients to primary and secondary cardiovascular prevention programs, without increasing the cost of the intervention. The use of a polypill in cardiovascular prevention can be effective as a prescription tool.
Medicine and Pharmacology, Cardiac and Cardiovascular Systems
Copyright:
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
.jpg)
